t0901317 and Renal-Insufficiency--Chronic

t0901317 has been researched along with Renal-Insufficiency--Chronic* in 2 studies

Other Studies

2 other study(ies) available for t0901317 and Renal-Insufficiency--Chronic

ArticleYear
Chronic kidney disease alters lipid trafficking and inflammatory responses in macrophages: effects of liver X receptor agonism.
    BMC nephrology, 2018, 01-27, Volume: 19, Issue:1

    Our aim was to evaluate lipid trafficking and inflammatory response of macrophages exposed to lipoproteins from subjects with moderate to severe chronic kidney disease (CKD), and to investigate the potential benefits of activating cellular cholesterol transporters via liver X receptor (LXR) agonism.

    Topics: Adult; Aged; Biological Transport; Female; Humans; Hydrocarbons, Fluorinated; Inflammation Mediators; Lipoproteins, HDL; Lipoproteins, LDL; Liver X Receptors; Macrophages; Male; Middle Aged; Protein Transport; Renal Insufficiency, Chronic; Sulfonamides; THP-1 Cells

2018
Increased Proinflammatory Cytokine Production and Decreased Cholesterol Efflux Due to Downregulation of ABCG1 in Macrophages Exposed to Indoxyl Sulfate.
    Toxins, 2015, Aug-14, Volume: 7, Issue:8

    One of the possible causes of enhanced atherosclerosis in patients with chronic kidney disease (CKD) is the accumulation of uremic toxins. Since macrophage foam cell formation is a hallmark of atherosclerosis, we examined the direct effect of indoxyl sulfate (IS), a representative uremic toxin, on macrophage function. Macrophages differentiated from THP-1 cells were exposed to IS in vitro. IS decreased the cell viability of THP-1 derived macrophages but promoted the production of inflammatory cytokines (IL-1β, IS 1.0 mM: 101.8 ± 21.8 pg/mL vs. 0 mM: 7.0 ± 0.3 pg/mL, TNF-α, IS 1.0 mM: 96.6 ± 11.0 pg/mL vs. 0 mM: 15.1 ± 3.1 pg/mL) and reactive oxygen species. IS reduced macrophage cholesterol efflux (IS 0.5 mM: 30.3% ± 7.3% vs. 0 mM: 43.5% ± 1.6%) and decreased ATP-binding cassette transporter G1 expression. However, lipid uptake into cells was not enhanced. A liver X receptor (LXR) agonist, T0901317, improved IS-induced production of inflammatory cytokines as well as reduced cholesterol efflux. In conclusion, IS induced inflammatory reactions and reduced cholesterol efflux in macrophages. Both effects of IS were improved with activation of LXR. Direct interactions of uremic toxins with macrophages may be a major cause of atherosclerosis acceleration in patients with CKD.

    Topics: Atherosclerosis; ATP Binding Cassette Transporter, Subfamily G, Member 1; ATP-Binding Cassette Transporters; Cell Line, Tumor; Cell Survival; Cholesterol; Cytokines; Down-Regulation; Humans; Hydrocarbons, Fluorinated; Indican; Liver X Receptors; Macrophages; Orphan Nuclear Receptors; Reactive Oxygen Species; Renal Insufficiency, Chronic; Sulfonamides

2015